| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/16/2002 | EP1171635A1 Electronically mediated nucleic acid amplification in nasba |
| 01/16/2002 | EP1171634A1 Amplification and sequencing primer pairs and use thereof |
| 01/16/2002 | EP1171629A1 Novel essential bacterial genes and their proteins |
| 01/16/2002 | EP1171628A2 Compound screening methods |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171624A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 01/16/2002 | EP1171623A2 Production of attenuated negative stranded rna virus vaccines |
| 01/16/2002 | EP1171621A1 Plant transformation method |
| 01/16/2002 | EP1171620A1 Acquired resistance genes in plants |
| 01/16/2002 | EP1171619A1 Regulated expression of genes in plant seeds |
| 01/16/2002 | EP1171618A2 Plant transformation process |
| 01/16/2002 | EP1171617A2 Enhancement of the immune response for vaccine and gene therapy applications |
| 01/16/2002 | EP1171616A1 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 01/16/2002 | EP1171615A2 Cell culture process for glycoproteins |
| 01/16/2002 | EP1171614A1 Dsp-4 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171613A1 Dsp-7 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171612A2 Telomerase-specific cancer vaccine |
| 01/16/2002 | EP1171611A1 Splice variant of p101 protein |
| 01/16/2002 | EP1171610A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis |
| 01/16/2002 | EP1171609A2 Lipoxygenase proteins and polynucleotides encoding the same |
| 01/16/2002 | EP1171608A2 Recombinant and mutant marek's disease virus |
| 01/16/2002 | EP1171607A1 Streptokinase fragments and their use for inhibiting cell death |
| 01/16/2002 | EP1171606A2 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 01/16/2002 | EP1171605A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171603A1 A process for producing purified biologically active, free form of recombinant human interferon gamma |
| 01/16/2002 | EP1171602A1 Anti-angiogenic intestinal peptides, zdint5 |
| 01/16/2002 | EP1171601A2 Nucleic acids encoding a mutt domain-containing polypeptide |
| 01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
| 01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
| 01/16/2002 | EP1171597A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171594A1 Vascular endothelial cell growth factor variants and uses thereof |
| 01/16/2002 | EP1171592A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171589A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 01/16/2002 | EP1171588A1 P element derived vector and methods for its use |
| 01/16/2002 | EP1171586A2 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171584A1 Magnetic dna extraction kit for plants |
| 01/16/2002 | EP1171583A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 01/16/2002 | EP1171581A1 Lipase variant |
| 01/16/2002 | EP1171580A2 Human homologues of fused gene |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171577A2 Anti-bacterial vaccine compositions |
| 01/16/2002 | EP1171573A1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171468A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 01/16/2002 | EP1171467A1 Axor-27, a g-protein coupled receptor |
| 01/16/2002 | EP1171466A2 G-protein coupled receptor and method of using same |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171460A1 48 human secreted proteins |
| 01/16/2002 | EP1171459A1 Angiopoietin-like proteins, crisp proteins and polynucleotides encoding same |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171456A1 50 human secreted proteins |
| 01/16/2002 | EP1171165A1 Intramyocardial injection of autologous bone marrow |
| 01/16/2002 | EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 01/16/2002 | EP1171154A2 Uses of mammalian ox2 protein and related reagents |
| 01/16/2002 | EP1171151A1 Thrombospondin-2 and uses thereof |
| 01/16/2002 | EP1171078A2 Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol |
| 01/16/2002 | EP1170994A1 Transgenic animals expressing salivary proteins |
| 01/16/2002 | EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
| 01/16/2002 | EP1170992A1 PURIFIED AND ISOLATED $i(piwi) FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME |
| 01/16/2002 | EP1023306A4 System and method for performing polynucleotide separations using liquid chromatography |
| 01/16/2002 | EP1007649B1 Methods to screen for transcription factor-coactivator interactions |
| 01/16/2002 | EP0998189A4 Carotenoid-associated proteins useful for high carotenoid accumulation and production in plants and other organisms |
| 01/16/2002 | EP0939833B1 USE OF A MUTATION IN THE GENE FOR HUMAN G-PROTEIN beta 3 SUB-UNIT FOR DIAGNOSING ILLNESSES |
| 01/16/2002 | EP0910570A4 Integrated nucleic acid hybridization devices based upon active surface chemistry |
| 01/16/2002 | EP0871732A4 Method of treating sepsis |
| 01/16/2002 | EP0862653B1 NUCLEIC ACID MOLECULES CAPABLE OF DISTINGUISHING THE ISOFORMS PrPc AND PrPSc OF PRION PROTEINS AND PROCESSES FOR THEIR PRODUCTION |
| 01/16/2002 | EP0854877B1 Metallocene-phosphoramidite conjugates, process for their preparation and their use |
| 01/16/2002 | EP0840791B1 Generation of immune responses to prostate-specific antigen (psa) |
| 01/16/2002 | EP0817859B1 Recombinant dna vectors for gene therapy |
| 01/16/2002 | EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 01/16/2002 | EP0782580A4 Parallel selex |
| 01/16/2002 | EP0743986B1 Heterologous dimeric proteins produced in heterokaryons |
| 01/16/2002 | EP0739423B1 Mesoscale polynucleotide amplification devices |
| 01/16/2002 | EP0672681B1 Novel antitumor peptide |
| 01/16/2002 | EP0672180B1 Oligonucleotide modulation of protein kinase c |
| 01/16/2002 | EP0645455B1 Acetobacter, plasmid originating therein, and shuttle vector constructed from said plasmid |
| 01/16/2002 | EP0515516B1 Methods for identifying heterofunctional fusion proteins |
| 01/16/2002 | EP0496875B1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 01/16/2002 | CN1331800A Method for gold deposition |
| 01/16/2002 | CN1331756A Genotyping cytochrome expression |
| 01/16/2002 | CN1331755A Method for indexing and determining relative concentration of expressed messenger RNAs |
| 01/16/2002 | CN1331754A Method for detecting gene affected by endocrine disruptor |
| 01/16/2002 | CN1331753A Essential genes from C albicans and method for screening antimycotic substances using said genes |
| 01/16/2002 | CN1331749A Method for producing ascorbic acid intermediates |
| 01/16/2002 | CN1331748A Method of recombination and agents useful for same |
| 01/16/2002 | CN1331747A Transgenic plants comprising counditionally lethal gene and its prodn. method |
| 01/16/2002 | CN1331746A Regulatory sequences useful for gene expression in plant embryo tissue |
| 01/16/2002 | CN1331745A Gene and proteins, and their use |
| 01/16/2002 | CN1331744A Gene coding for acyltransferase of oil seed rape and uses thereof |
| 01/16/2002 | CN1331743A Method for producing chiral carboxylic acids from nitriles with assistance of nitrilase or microorganisms which contain gene for nitrilase |
| 01/16/2002 | CN1331742A Lipolytic enzyme varints |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/16/2002 | CN1331700A Generation of antibodies using polynucleotide vaccination in avian species |